Trial intelligence / Profile preview

Propofol-lidocaine versus propofol-fentanyl sedation for combined gastroscopy and colonoscopy in adults

TCTR20261102003Phase 1Recruiting

Sponsor
Hue University of Medicine and Pharmacy
Start
Jun 2026
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of propofol, lidocaine and fentanyl in None (2 arms), sponsored by Hue University of Medicine and Pharmacy. Primary endpoint: Adequate sedation rate. Started Jun 2026; status: recruiting.

02

Drugs

propofollidocainefentanyl

Beyond the preview

Go deeper on TCTR20261102003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20261102003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call